Skip to content

Economic Evaluation in Cardiology: Remote Monitoring of Pacemakers

Economic Evaluation in Cardiology: Remote Monitoring of Pacemakers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02234245
Enrollment
83
Registered
2014-09-09
Start date
2012-10-31
Completion date
2018-10-31
Last updated
2023-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Keywords

Follow-Up studies, Biological Pacemakers, Telemedicine, Efficiency

Brief summary

The purpose of this research is to estimate the outcomes in health and cost of the follow-up of patients with pacemakers. The initial hypothesize of this study is that remote monitoring of pacemaker will show a best relation of outcomes in costs and effectiveness than the conventional follow-up in hospital.

Detailed description

Cardiovascular Diseases are a major cause of global morbidity and mortality, being responsible according to the World Health Organization of the 30% of overall mortality. Since 2001 that the first pacemaker of remote monitoring was implanted in Europe, more than 300,000 pacemaker have been implanted around the world. Despite this sharp expansion, the scientific evidence on economic evaluations of pacemaker with remote monitoring is very limited, and in our knowledge, studies including informal costs have not been conducted. In the field of cardiology, telemedicine allows consultations with patients through monitoring systems and remote communication analyzing the ongoing heart rates of people with pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy and subcutaneous Holter. The use of remote monitoring may save time and efforts to both healthcare professionals and patients, including their informal caregivers, reducing the number of follow up visits to the hospital and reducing the associated costs with patient follow-up, which will help to improve sustainability of healthcare services. During the 12 months of study, the patients with implant of pacemakers of both groups will be assessed of the same parameters, in 4 different moments (pre-implant and months 1, 6, 12 and 5 years post-implantation). The study will estimate: 1) The Clinical features of the patients. 2) The effectiveness through of administration of health-related quality of life, functional capacity questionnaires and 3) Finally, the hospital and informal costs of patients with pacemakers will be estimated by the researches.

Interventions

Telemedicine System is used in remote monitoring group

Sponsors

Universidad de Almeria
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be 18 years of age * Have a pacemaker implanted * Understand and be able to properly perform self-monitoring at home

Exclusion criteria

* Be participating in another study * Refuse to participate in the study * Have implanted a different cardiac device to the pacemaker

Design outcomes

Primary

MeasureTime frameDescription
Clinical features12 monthsSelected variables from the medical history records: * gender * age * indication for the implantation of the pacemaker. * comorbidities * pharmacological treatment * vital signs * pacemaker parameters

Secondary

MeasureTime frameDescription
Functional capacity5 yearsDuke Activity Status Index (DASI).
Direct costs5 yearsDirect costs taken into account: * pacemakers' costs´(device implanted) * hospitalizations' costs * consultations' costs (hospital) * prescribed medical transport's cost * health personnel costs * pharmaceutical costs
Indirect cost5 yearsMaintenance of the medical consultation (hospital): * electricity * cleaning * furniture * Health fungible * equipment investment
Health-Related Quality of Life5 yearsEuroQol-5Dimensions (EQ-5D)
Number of patients with Adverse Events5 yearsNumber of patients with Adverse Events \- type of Adverse Events diagnosed
Consultations and Hospitalizations unscheduled5 years\- number of unscheduled visits and hospitalizations
Informal costs5 yearsCosts related to the care and displacements of patients to hospital: * displacement costs to hospital * Accommodation costs * Cost of meals * Costs for caregivers

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026